| 1 |
34691358 | THAP9-AS1 Promotes Tumorigenesis and Reduces ROS Generation through the JAK2/STAT3 Signaling Pathway by Increasing SOCS3 Promoter Methylation in Osteosarcoma. | 2021 |
1 |
| 2 |
26847351 | Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. | 2016 Feb 4 |
2 |
| 3 |
27666544 | [Methylation Status of the SOCS3 Gene Promoter in H2228 Cells and
EML4-ALK-positive Lung Cancer Tissues]. | 2016 Sep 20 |
1 |
| 4 |
25628929 | Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma. | 2015 |
1 |
| 5 |
24996521 | SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. | 2014 Dec |
1 |
| 6 |
23432547 | Gene methylation and silencing of SOCS3 in mantle cell lymphoma. | 2013 May |
2 |
| 7 |
22739025 | IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer. | 2012 Oct |
5 |
| 8 |
21934357 | Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma. | 2011 Aug |
2 |
| 9 |
19929568 | Defective interleukin-4/Stat6 activity correlates with increased constitutive expression of negative regulators SOCS-3, SOCS-7, and CISH in colon cancer cells. | 2009 Dec |
1 |
| 10 |
18507841 | SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro. | 2008 May 28 |
2 |
| 11 |
17241887 | Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. | 2007 Jan |
2 |
| 12 |
17273770 | Methylation status of the SOCS3 gene in human malignant melanomas. | 2007 Mar |
3 |
| 13 |
17376806 | Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. | 2007 Aug |
1 |
| 14 |
16007169 | SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. | 2005 Oct 6 |
2 |
| 15 |
16007195 | Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. | 2005 Sep 22 |
1 |